Gadodiamide CAS NO.131410-48-5

Product Name:    Gadodiamide
Synonyms:    2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;Gd-DTPA-BMA;S-041;GADODIAMIDE (500 MG);gadolinium 2-[bis[2-(carboxylatomethyl-(methylcarbamoylmethyl)amino)ethyl]amino]acetate;GADODIAMIDE;Omniscan;[5，8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2，5，8，11-tetraaza-tridecan-13-oato(3-)]gadolinium
CAS:    131410-48-5
MF:    C16H26GdN5O8
MW:    573.658
EINECS:    
Product Categories:    
Mol File:    131410-48-5.mol

storage temp.     Inert atmosphere,2-8°C
CAS DataBase Reference    131410-48-5
Safety Information
HS Code     2846909000
Hazardous Substances Data    131410-48-5(Hazardous Substances Data)
Toxicity    LD50 i.v. in mice: 14 mmol/kg (Chang)
MSDS Information
Gadodiamide Usage And Synthesis
Uses    efers to the substance containing the water of coordination and multiple (x) waters of hydration.
Definition    ChEBI: A non-ionic gadolinium chelate having a macrocyclic triamine framework. It is used as a paramagnetic contrast agent in magnetic resonance imaging (MRI).
General Description    Gadodiamide is a clear,colorless to slightly yellow, gadolinium-based contrastagent indicated to visualize lesions with abnormal vascularityin the CNS and body. It is a nonionic gadoliniumcomplex administered by intravenous injection with an osmolalityof 2.8 times that of plasma. Gadodiamide decreasesboth the T1 and T2 relaxation times in tissueswhere it is distributed. In clinical MRI, the effect is primarily on the T1 relaxation time resulting in an increase inT1-weighted sequence signal intensity.